We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$39.9B
AUM Growth
+$3.39B
Cap. Flow
+$1.89B
Cap. Flow %
4.72%
Top 10 Hldgs %
7.79%
Holding
3,456
New
750
Increased
762
Reduced
684
Closed
884

Top Buys

Rank Stock Value
1
CARR icon
Carrier Global
CARR
+$293M
2
HON icon
Honeywell
HON
+$209M
3
NSC icon
Norfolk Southern
NSC
+$200M
4
WMT icon
Walmart Inc
WMT
+$199M
5
CMCSA icon
Comcast
CMCSA
+$182M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$286M
2
TJX icon
TJX Companies
TJX
+$198M
3
ASML icon
ASML
ASML
+$187M
4
ADBE icon
Adobe
ADBE
+$181M
5
INTU icon
Intuit
INTU
+$180M

Sector Composition

Rank Sector Weight
1 Industrials 11.39%
2 Technology 10.6%
3 Consumer Discretionary 10.18%
4 Financials 9.8%
5 Healthcare 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
3026
PUT
Insulet
PODD
$9.9B
-34,800
Closed -$10.2M
PPG icon
3027
PPG Industries
PPG
$25.5B
-5,969
Closed -$751K
PRDO icon
3028
Perdoceo Education
PRDO
$1.96B
-64,784
Closed -$900K
PRG icon
3029
PROG Holdings
PRG
$1.67B
-345
Closed -$5.83K
PRGO icon
3030
Perrigo
PRGO
$1.7B
-971,936
Closed -$33.1M
PRLB icon
3031
Protolabs
PRLB
$2.17B
-200
Closed -$5.11K
PRPL icon
3032
Purple Innovation
PRPL
$31.6M
-2,078
Closed -$249K
PRTA icon
3033
Prothena Corp
PRTA
$469M
-1,115
Closed -$67.2K
PSMT icon
3034
Pricesmart
PSMT
$5.4B
-484
Closed -$29.4K
P
3035
PUT
Everpure Inc
P
$37B
-157,500
Closed -$4.21M
PTEN icon
3036
Patterson-UTI
PTEN
$4.18B
-33,067
Closed -$557K
PZZA icon
3037
Papa John's
PZZA
$801M
-169,709
Closed -$14M
QCOM icon
3038
PUT
Qualcomm
QCOM
$171B
-30,400
Closed -$3.34M
QDEL icon
3039
QuidelOrtho
QDEL
$992M
-413,033
Closed -$35.4M
QLYS icon
3040
Qualys
QLYS
$6.47B
-163,982
Closed -$18.4M
QNST icon
3041
QuinStreet
QNST
$1.17B
-23,776
Closed -$341K
QRVO icon
3042
Qorvo
QRVO
$8.5B
-428,385
Closed -$43.5M
R icon
3043
Ryder
R
$10B
-323
Closed -$27K
RACE icon
3044
Ferrari
RACE
$71.3B
-69,589
Closed -$14.9M
RAMP icon
3045
LiveRamp
RAMP
$2.3B
-6,677
Closed -$157K
RARE icon
3046
Ultragenyx Pharmaceutical
RARE
$2.63B
-1,219
Closed -$56.5K
RCKT icon
3047
Rocket Pharmaceuticals
RCKT
$382M
-542
Closed -$10.6K
RCUS icon
3048
Arcus Biosciences
RCUS
$3.67B
-22,025
Closed -$455K
RDWR icon
3049
Radware
RDWR
$1.23B
-11,859
Closed -$234K
REGN icon
3050
Regeneron Pharmaceuticals
REGN
$81.7B
-33,457
Closed -$25.2M

Similar funds

Balyasny Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Balyasny Asset Management held 3,456 positions worth $39.9B, up 9.3% from $36.5B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Balyasny Asset Management deployed $1.89B of net new capital in Q1 2023, opening 750 new positions and adding to 762 existing holdings. Its largest new stake was Honeywell: 1,110,808 shares worth $200M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $286M trimmed.

  • Balyasny Asset Management's largest Q1 2023 buy was Honeywell: 1,110,808 shares worth $200M.
  • Balyasny Asset Management added most to Carrier Global in Q1 2023, an estimated $293M increase.
  • Balyasny Asset Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $286M.
  • Balyasny Asset Management fully exited STORE Capital Corporation in Q1 2023, selling an estimated $144M.
  • Balyasny Asset Management's ten largest holdings make up 7.8% of its $39.9B portfolio in Q1 2023.
  • Balyasny Asset Management opened 750 new positions and closed 884 in Q1 2023.
  • Balyasny Asset Management's portfolio value rose 9.3% quarter-over-quarter to $39.9B.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.